Manhattan Psychiatric Center Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: New York NY United States (1848)

Organization Overview

First Clinical Trial
2003
NCT00395031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

clozapine (clozaril) (1 trial)

varenicline (chantix) (1 trial)

Drugs in Phase 3 Trials (2)

quetiapine (seroquel) (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 2 Trials (1)

modafinil (provigil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognition Disorders (Phase 4)

Cognitive Dysfunction (Phase 4)

Disease (Phase 4)

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5